Skip to main content
Premium Trial:

Request an Annual Quote

Aurora, Merck Partner to Investigate Gene Function


SAN DIEGO--Aurora Biosciences has formed two new functional genomics collaborations with Merck in which Aurora will apply its GenomeScreen technology to investigate cell signaling pathways and gene function for selected Merck therapeutic programs. Aurora said GenomeScreen enables gene discovery, target identification, and signal pathway elucidation. Aurora will receive an upfront payment from Merck, possible additional research support fees, and certain provisions for revenues in the event that drugs developed through the collaboration are commercialized. Merck will receive a license to use in basic research and drug discovery the data and materials resulting from the deal.

Filed under

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.